# Treatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin (Gralise)

> **NCT01623271** · NA · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 5 (actual)

## Conditions studied

- Complex Regional Pain Syndrome I (CRPS I)

## Interventions

- **DRUG:** Gabapentin

## Key facts

- **NCT ID:** NCT01623271
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-05
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Due to limited population of research participants.
- **Last updated:** 2020-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01623271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01623271, "Treatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin (Gralise)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01623271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*